{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Brookhaven",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "84353",
      "recalling_firm": "Amneal Pharmaceuticals, Inc.",
      "address_1": "50 Horseblock Rd",
      "address_2": "N/A",
      "postal_code": "11719-9509",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Product was distributed throughout the United States.",
      "recall_number": "D-0614-2020",
      "product_description": "Ranitidine Syrup Oral Solution 15 mg/mL 6. fl. oz. (473 mL), NDC 65162-664-90.",
      "product_quantity": "N/A",
      "reason_for_recall": "CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API",
      "recall_initiation_date": "20191122",
      "center_classification_date": "20191209",
      "report_date": "20191218",
      "code_info": "06648001A 11/2019  06648003A 4/2020  06649001A 1/2021",
      "more_code_info": ""
    }
  ]
}